VivoSim Labs, INC.

VIVSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$144,000

▲ 32.1% YoY

Net Income

-$2.5M

▲ 83.0% YoY

EPS

$-1.70

▲ 91.2% YoY

Cash

$11.3M

▲ 289.9% YoY

FY 2025 · As of 2025-03-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.